Raul Cordoba: End points in clinical trials in diffuse large B-cell lymphoma

Raul Cordoba shared on X:

“Hematology End points in clinical trials in diffuse large B-cell lymphoma: time for more dialogue?”

End points in clinical trials in diffuse large B-cell lymphoma: time for more dialogue?

Authors: Evgeny Degtyarev, Natacha Bolaños, Joshua D Brody, Aby Buchbinder, Marc Buyse, Miriam Fuchs, Susan Halabi, Robert Hemmings, Aisha Masood, Simon Newsome, Claire Saxton, Lorna Warwick, Nigel A Yateman, Emmanuel Zuber

More posts featuring Raul Cordoba on oncodaily.com

Raúl Córdoba Mascuñano, MD, PhD is a specialist in hematology and hemotherapy. He is the Chair of Community Stakeholder Committee at European Hematology Association (EHA) and Coordinator of the Lymphoma Unit and Associate Chief of Hematology Department at Jiménez Díaz Foundation. He is the principal investigator for numerous clinical trials for non-Hodgkin lymphoma, Hodgkin lymphoma, chronic lymphocytic leukemia and other chronic lymphoproliferative syndromes. He is a member of the ethical review board at his current workplace.